High Point Advisor Group LLC Bio Xcel Therapeutics, Inc. Transaction History

High Point Advisor Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $290,490 - $390,285	-12,185 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$29.06 - $38.83 $14,181 - $18,949	-488 Reduced 3.85%	12,185 $354,000
Q1 2021 Apr 12, 2021	BUY	$39.04 - $64.6 $13,039 - $21,576	334 Added 2.71%	12,673 $455,000
Q4 2020 Feb 10, 2021	SELL	$42.46 - $56.58 $43,096 - $57,428	-1,015 Reduced 7.6%	12,339 $737,000
Q3 2020 Nov 06, 2020	SELL	$37.44 - $64.63 $181,621 - $313,520	-4,851 Reduced 26.65%	13,354 $717,000
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $185,538 - $618,216	10,530 Added 137.2%	18,205 $974,000
Q1 2020 May 01, 2020	BUY	$12.26 - $41.14 $91,202 - $306,040	7,439 Added 3152.12%	7,675 $236,000
Q1 2020 Apr 27, 2020	BUY	$12.26 - $41.14 $2,893 - $9,709	236 New	236 $7.68 Million

3.06M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $70.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.